A Randomized-Controlled Trial to Examine the Effects of a Daily Probiotic Supplement on Common Symptoms of Menopause
NCT ID: NCT06148714
Last Updated: 2024-11-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2023-12-01
2024-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Menopausal Symptoms Probiotic Study
NCT06446869
The Effects of a Novel Probiotic Supplement on Menopausal Symptoms and Bone Health
NCT04001088
One Week Clinical Study in Subjects With Menopausal Symptoms
NCT06794021
Impact of a Probiotic Combination on Quality of Life and Symptoms in Peri- and Postmenopausal Women
NCT06604234
Randomized Placebo Controlled Clinical Study of an Oral Product in Subjects With Menopausal Symptoms
NCT06787443
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Provitalize Probiotic
Participants will take 2 capsules every morning on an empty stomach before their first meal of the day.
Provitalize Natural Menopause Probiotic
Supplement containing a Probiotic blend of Bifidobacterium breve, Lactobacillus Gasseri, and Bifidobacterium animalis subsp. Lactis.
Placebo
Participants will take 2 capsules every morning on an empty stomach before their first meal of the day.
Placebo
Placebo comparator containing Pure hydroxypropyl methylcellulose (HPmC) with food dye.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Provitalize Natural Menopause Probiotic
Supplement containing a Probiotic blend of Bifidobacterium breve, Lactobacillus Gasseri, and Bifidobacterium animalis subsp. Lactis.
Placebo
Placebo comparator containing Pure hydroxypropyl methylcellulose (HPmC) with food dye.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must experience hot flashes and/or night sweats at least once per day
* Must also be experiencing at least two symptoms of menopause, such as sleep disturbances, mood changes, fatigue and lack of energy, changes in sexual function, urinary changes, weight gain, or vaginal changes
* Can be either natural or surgical menopause
* Has not had a period in the last 12 consecutive months
* Willing to adhere to the study protocol for the duration of the study
* Willing to stop taking any other herbal remedies or supplements for the duration of the study
* Self-reports as "generally healthy"
* Has never taken Provitalize before
* No planned invasive medical procedures for the duration of the study or in the three weeks leading up to the study start
Exclusion Criteria
* Unwilling to stop taking any other herbal remedies or supplements for the duration of the study
* Current use of conventional hormone replacement therapies, or plan to start during the study duration
* Current use of hormonal birth control, or plan to start during the study duration
* Known allergies or hypersensitivities to any product ingredients
* Current or history of uterine fibroids, endometriosis, polycystic ovarian syndrome, or history of abnormal pap smear
* Anyone with any known severe allergies requiring the use of an epi-pen
* Unwilling to adhere to the study protocol
* Anyone living with uncontrolled or chronic health disorders, including oncological or psychiatric disorders
* Pregnant, breastfeeding or trying to conceive
* Currently taking a prescription sleep aid
45 Years
65 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Citruslabs
INDUSTRY
Maneuver Marketing
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Citruslabs
Santa Monica, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20379
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.